The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer

Table 4

Bivariate analysis was used to determine which of the above factors was more likely to prompt physicians to screen for osteoporosis.

	Odds ratio	95% CI
Number of ADT treatments	1.24	1.096–1.403
Age	0.73	0.911–1.040
Gleason score	1.082	0.687–1.703
Years since diagnosis	1.109	0.915–1.345
Smoking history	1.43	0.565–3.621
Stage 1 A or B or C versus Stage 3 A or B or C	0.959	0.264–3.484
Stage 2 A or B or C versus Stage 3 A or B or C	1.61	0.539–4.808